Remove DNA Remove Genomics Remove Recombinant DNA Technology Remove Research
article thumbnail

The DDW Podcast: 2022 in review 

Drug Discovery World

Recombinant DNA technology and its impact on modern drug discovery . Exploring the microbiome: how it is shaping preclinical research . What can we learn from the genome? . Is genomic data the new frontier in drug discovery? . Catch up on the Sitting Down With podcast episodes released in 2022: .

article thumbnail

Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies

Cloudbyz

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins.

Gene 71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading innovators in gene splicing using nucleases for the pharmaceutical industry

Pharmaceutical Technology

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

Recombinant DNA technology and improved protein purification techniques further contributed to our understanding and explorations of drug targets. Networks also allow us to integrate diverse types of biological pathways, literature, genomics, transcriptomics, proteomics and ligand-binding studies.